We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
-11.33%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$15.1B
AUM Growth
-$1.81B
(-11%)
Cap. Flow
+$464M
Cap. Flow
% of AUM
3.07%
Top 10 Holdings %
Top 10 Hldgs %
22.68%
Holding
1,302
New
77
Increased
452
Reduced
571
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$835M |
| 2 |
Procter & Gamble
PG
|
+$87.9M |
| 3 |
Alibaba
BABA
|
+$50.4M |
| 4 |
Merck
MRK
|
+$47.1M |
| 5 |
Target
TGT
|
+$42.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$105M |
| 2 |
Texas Instruments
TXN
|
+$79.4M |
| 3 |
TSMC
TSM
|
+$77.5M |
| 4 |
Cisco
CSCO
|
+$55.8M |
| 5 |
NextEra Energy
NEE
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.2% |
| 2 | Healthcare | 16.02% |
| 3 | Financials | 13.93% |
| 4 | Communication Services | 9.97% |
| 5 | Consumer Discretionary | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Lincoln Electric
LECO
$15.2B
| $747K | ﹤0.01% |
9,600
| – | – |
|
752
Iron Mountain
IRM
$36.3B
| $745K | ﹤0.01% |
22,085
-1,515
| -6% | -$49.7K |
|
753
Pacira BioSciences
PCRX
$977M
| $744K | ﹤0.01% |
17,893
-2,655
| -13% | -$124K |
|
|
PE
754
DELISTED
PARSLEY ENERGY INC
PE
| $741K | ﹤0.01% |
45,850
+19,774
| +76% | +$451K |
|
|
TPIC
755
DELISTED
TPI Composites
TPIC
| $730K | ﹤0.01% |
30,000
+5,000
| +20% | +$127K |
|
|
VEDL
756
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $726K | ﹤0.01% |
64,846
+45,000
| +227% | +$514K |
|
|
TARO
757
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $725K | ﹤0.01% |
+8,347
| New | +$805K |
|
758
Children's Place
PLCE
$58.3M
| $713K | ﹤0.01% |
7,666
+351
| +5% | +$43.8K |
|
|
VNE
759
DELISTED
Veoneer, Inc.
VNE
| $712K | ﹤0.01% |
28,000
+8,000
| +40% | +$281K |
|
760
Tilray
TLRY
$594M
| $711K | ﹤0.01% |
1,000
-7,950
| -89% | -$8.72M |
|
761
NIO
NIO
$11.9B
| $707K | ﹤0.01% |
+110,000
| New | +$765K |
|
762
Repligen
RGEN
$9.21B
| $705K | ﹤0.01% |
13,950
-3,250
| -19% | -$191K |
|
|
FDC
763
DELISTED
First Data Corporation
FDC
| $704K | ﹤0.01% |
39,613
+1,272
| +3% | +$24.8K |
|
|
BPMC
764
DELISTED
Blueprint Medicines
BPMC
| $702K | ﹤0.01% |
13,875
-2,405
| -15% | -$146K |
|
|
CLR
765
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $701K | ﹤0.01% |
17,227
+2,731
| +19% | +$140K |
|
|
MDSO
766
DELISTED
Medidata Solutions, Inc.
MDSO
| $701K | ﹤0.01% |
10,700
-1,000
| -9% | -$70.6K |
|
767
Pinnacle West Capital
PNW
$12B
| $696K | ﹤0.01% |
7,726
-716
| -8% | -$61.7K |
|
|
MDCO
768
DELISTED
Medicines Co
MDCO
| $696K | ﹤0.01% |
36,700
-1,100
| -3% | -$25.6K |
|
769
Agnico Eagle Mines
AEM
$91.3B
| $692K | ﹤0.01% |
16,996
-220,996
| -93% | -$8.14M |
|
770
Camden Property Trust
CPT
$11B
| $692K | ﹤0.01% |
7,609
-18,898
| -71% | -$1.73M |
|
771
EPR Properties
EPR
$4.62B
| $689K | ﹤0.01% |
+10,710
| New | +$737K |
|
|
TLND
772
DELISTED
Talend S.A. American Depositary Shares
TLND
| $681K | ﹤0.01% |
19,037
+16,957
| +815% | +$817K |
|
773
Medpace
MEDP
$16.7B
| $679K | ﹤0.01% |
13,000
-3,000
| -19% | -$165K |
|
774
Liberty Broadband Class C
LBRDK
$5.17B
| $675K | ﹤0.01% |
8,998
-16
| -0.2% | -$1.28K |
|
775
Sabre
SABR
$835M
| $674K | ﹤0.01% |
30,219
+14,386
| +91% | +$348K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q4 2018 Portfolio in Review
As of Q4 2018, DekaBank Deutsche Girozentrale held 1,302 positions worth $15.1B, down 11% from $16.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
DekaBank Deutsche Girozentrale deployed $464M of net new capital in Q4 2018, opening 77 new positions and adding to 452 existing holdings. Its largest new stake was Linde: 5,283,074 shares worth $840M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $105M trimmed.
- DekaBank Deutsche Girozentrale's largest Q4 2018 buy was Linde: 5,283,074 shares worth $840M.
- DekaBank Deutsche Girozentrale added most to Procter & Gamble in Q4 2018, an estimated $87.9M increase.
- DekaBank Deutsche Girozentrale's biggest Q4 2018 reduction was Johnson & Johnson, cutting an estimated $105M.
- DekaBank Deutsche Girozentrale fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $46.5M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $15.1B portfolio in Q4 2018.
- DekaBank Deutsche Girozentrale opened 77 new positions and closed 126 in Q4 2018.
- DekaBank Deutsche Girozentrale's portfolio value fell 11% quarter-over-quarter to $15.1B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2018, filed 12 Feb 2019.